On this page
At 10:00 a.m., 12 founders arrive with pitch decks. By 4:00 p.m., each should leave with a list of evidence gaps, decision risks, and the next document to build. That is the job of startup diligence clinics: turn vague investor feedback into a repeatable operating review. For partners who support founders across India, a well-run clinic creates a sharper pipeline without pretending every startup is ready to raise.
Define the clinic outcome before inviting founders
A startup diligence clinic is not a pitch event, a mentoring hour, or a founder networking session. It is a structured review where founders present evidence, reviewers test assumptions, and the group identifies what must be true before the company can pursue the next capital, partnership, or growth decision. If the outcome is unclear, the clinic becomes a long list of opinions with no owner and no deadline.
Start by choosing one decision the clinic will help founders prepare for. That may be whether to begin an angel round, whether to approach an institutional investor, whether to hire a sales lead, or whether to run a deeper product validation cycle. A founder who is still unsure about the customer problem needs a different clinic from one who has revenue but cannot explain retention or margins.
Design rule: Every founder should leave with three outputs: a diligence scorecard, a ranked list of gaps, and a 30-day action plan. Without these, the clinic has created activity rather than progress.
Partners should also decide what the clinic will not do. Do not promise funding decisions, introductions, or commercial contracts during the session. Those outcomes may follow, but diligence works only when the room can identify weaknesses without founders feeling pressured to perform confidence.
Build an intake that reveals evidence gaps
The intake form determines the quality of the clinic. If you ask founders for a deck, a LinkedIn profile, and a one-line problem statement, reviewers will spend the session extracting basic facts. Ask for evidence instead: customer interviews, sales records, product usage, pricing logic, ownership structure, and the assumptions behind the fundraising ask.
Keep the intake short enough to complete, but demanding enough to expose preparation quality. Founders do not need polished reports. They need to show what they know, what they have measured, and where they are still making a judgment call. A simple folder structure also makes reviews faster and lets the founder reuse the material later.
- Company brief: problem, customer, product, market entry point, and business model.
- Customer evidence: interview notes, pilot outcomes, letters of intent, invoices, or usage data where available.
- Product evidence: product walkthrough, roadmap, technical dependencies, and known delivery risks.
- Commercial evidence: pricing, sales cycle, gross margin assumptions, channel plan, and customer concentration.
- Fundraising evidence: capital required, use of funds, runway assumptions, cap table, and target investor profile.
Require founders to submit the material several days before the clinic. Reviewers need time to read it and form questions. A clinic should test the business, not reward the founder who can improvise the best answer in a room.
Run startup diligence clinics by company stage
One clinic cannot apply the same test to every startup. An idea-stage founder may have no revenue and no product analytics, while a company preparing for a seed round may need to defend conversion, retention, unit economics, and hiring plans. Treating both companies the same produces poor advice and false comparisons.
Split the clinic into tracks based on the decision in front of the founder. Early-stage teams should be examined for problem clarity, customer access, speed of validation, and the smallest product they can test. Later-stage teams should be examined for repeatability: whether demand is real, whether revenue is predictable enough, whether the team can execute, and whether the capital ask matches the operating plan.
| Founder stage | Primary diligence question | Evidence to request |
|---|---|---|
| Idea | Is this problem painful enough to solve now? | Customer interviews, defined user, problem frequency |
| Early product | Can the team validate demand with a narrow product? | Prototype, pilot plan, user feedback, pricing test |
| Early revenue | Is there a repeatable path to acquire and retain customers? | Invoices, funnel data, sales process, customer cohorts |
| Fundraising-ready | Does the capital plan support a measurable next milestone? | Financial model, cap table, use of funds, investor list |
At Nebula, our work runs from validation through product, fundraising, and go-to-market because these questions compound. Partners can use the same discipline without trying to replicate a full venture-building engagement.
Use a scorecard, not a verdict
A clinic should not end with a reviewer declaring that a startup is investable or not investable. That label is usually too broad, too early, and too dependent on the reviewer’s own preferences. A scorecard gives founders a clearer picture: where evidence is strong, where it is incomplete, and what risk remains before the next decision.
Score each area against evidence rather than presentation quality. A confident founder with thin customer proof should score lower than a less polished founder who can show repeat usage, signed pilots, or a disciplined testing process. Give each score a written reason so the founder understands what would change it.
Use four ratings: proven, promising, unproven, and material risk. These are easier to act on than a single number because they force the reviewer to state what evidence is missing.
Keep the scorecard consistent across every clinic. Reviewers may disagree on whether a market is attractive, but they should assess the same core areas: customer, product, team, commercial model, financial plan, and funding readiness. Consistency helps a partner see patterns across its founder pipeline and decide where to deploy follow-on support.
Our process is built around stages from Idea through Scale. A partner clinic should similarly make the founder’s current stage visible before prescribing the next move.
If you are designing a first clinic and need a tighter fundraising lens, Apply for Nebula 1.0. Our current live program is a two-week fundraising sprint for founders who need to turn their raise preparation into a focused execution plan.
Choose reviewers for the work, then brief them
The strongest reviewer is not always the person with the biggest title. A diligence clinic needs people who can read a cap table, interrogate a sales process, identify product delivery risk, or spot where a founder has confused interest with demand. Build the panel around the founder cohort and the clinic’s stated decision.
Give every reviewer a briefing note before the session. It should explain the scoring system, the founder’s stage, the documents available, and the rules of engagement. Without this preparation, reviewers often repeat basic questions, chase their own interests, or give contradictory advice that the founder cannot use.
- Ask reviewers to identify gaps, not to perform expertise.
- Require questions to be tied to a decision risk or missing evidence.
- Assign one lead reviewer for each company to consolidate feedback.
- Limit tactical suggestions unless they directly address a scored gap.
- Record commitments only when a reviewer has named an owner and timeline.
Use a moderator who can stop unhelpful debates. Founders should answer direct questions, but they should not spend half the session defending choices that do not affect the next milestone. The moderator’s job is to protect the agenda, make disagreement useful, and ensure each startup receives comparable review time.
Make follow-through part of the clinic
The clinic ends only when the founder has converted feedback into work. Within 48 hours, send the scorecard, reviewer notes, and a short action memo. The memo should name the top three gaps, the evidence required to close each gap, the owner, and the date for a follow-up review.
Do not give founders 20 tasks. A long list signals that the reviewers failed to prioritise. A company preparing to raise may need to reconcile its cap table, define a use-of-funds plan, and prove a key commercial assumption before doing anything else. A company still validating the problem may need customer conversations before it has any reason to refine a financial model.
Watch for advice debt: when founders receive more suggestions than they can test, they begin collecting opinions instead of making decisions. Close the clinic with fewer actions and stronger accountability.
Schedule a checkpoint after the action period. The purpose is not to grade the founder; it is to see whether the work changed the risk profile. Partners can then route founders to the right next support: customer discovery, product execution, fundraising preparation, or a deeper operating engagement.
Where a founder needs embedded work across validation, product, fundraising, and go-to-market, a one-day clinic should be the handoff point, not the final intervention. Our engagement models are structured for founders who need operators working alongside them through those decisions.
Measure the partner program, not the event
Partners often measure clinic attendance, number of mentors, or founder satisfaction. Those measures are useful for logistics, but they do not tell you whether the clinic improved company readiness. Track what changed after the review: how many founders completed their action plans, how many closed defined evidence gaps, and how many were ready for the next decision.
Build a simple operating dashboard for each clinic cycle. It should show the founder stage at entry, the highest-risk diligence category, the agreed next milestone, and progress at the follow-up checkpoint. Over time, this gives partners a clearer view of recurring bottlenecks across their founder base.
- Which evidence gap appears most often: customer proof, product delivery, team, or financial planning?
- Which founder stage is being admitted before it is ready?
- Which workshops or operator support reduce repeat gaps?
- Which companies progress to a defined next milestone after follow-up?
- Which reviewers produce clear, usable actions for founders?
This is where startup diligence clinics become a partner capability rather than an occasional event. The partner learns how to identify readiness earlier. The founder receives a clearer path. The support team can place scarce time where it changes the company’s next outcome.
We are a venture builder in Tamil Nadu, building for India, and we work as co-builders rather than advisors. If your organisation wants to run diligence clinics that lead to deeper founder progress, Partner with us.
A good clinic does not produce a louder pitch deck. It produces a founder who knows the next proof point, the risk behind it, and the work required to earn the next conversation.
Enjoyed this? Get the next one in your inbox.
Fundraising guides and validation frameworks, every two weeks. No spam.
Frequently asked questions
What is a startup diligence clinic?
A startup diligence clinic is a structured review where founders present business evidence, reviewers test key risks, and each company leaves with a scorecard and action plan.
Who should attend a startup diligence clinic?
Founders should attend with the person responsible for the next milestone, while reviewers should be selected for relevant experience in customer, product, commercial, financial, or funding questions.
How long should a startup diligence clinic run?
The session length should match the number and stage of companies, but every founder needs enough protected time for document review, questions, scoring, and agreed next actions.
Ready to build your startup?
We work with a small number of founders each year — mentorship, fundraising support, and a co-founder network included.
Start a conversation
Talk to the founder directly. We reply within two working days.
Applying to Nebula 1.0? Apply here →